Standard Biotools Inc.
Could not find a ticker for this position, may be a filing error
A maker of scientific instruments used by biomedical researchers to study individual cells and proteins. Its three platforms—CyTOF mass cytometry, Hyperion spatial proteomics, and Biomark genomics—are sold to academic labs, translational centers, and biopharma companies. Founded in 1999 as Mycometrix and renamed Fluidigm in 2001 (a play on the "fluid" microchips it builds), the company became Standard BioTools in 2022, after its microfluidics "integrated fluidic circuits" were born from a Caltech lab that manipulates fluids on chips much like electronics handle electrons.
5.25% Convertible Senior Notes due 2024
Granted 58.2K · Bought 10.92M
Granted 46.47M · Bought 2.30M
Bought 12.71M
Granted 21.93M · Bought 1.20M
Bought 3.06M
Granted 13.99M
Bought 881.7K
Bought 59.0K
Bought 73.4K
Bought 5.31M
Bought 35.0K
Bought 48.8K
Sold 2.07M
Granted 7.24M · Sold 15.3K
Granted 2.85M · Sold 4.2K
Bought 1.00M
Granted 1.05M · Sold 38.6K
Bought 1.20M
Granted 460.5K
Granted 365.8K · Bought 86.0K
Granted 554.0K · Bought 50.0K · Sold 211.9K
Granted 423.9K
Granted 335.3K
Granted 557.2K · Bought 104.0K · Sold 84.8K
Granted 310.0K
Granted 159.9K · Bought 110.4K · Sold 76.5K
Granted 316.2K
Granted 109.8K · Bought 92.3K · Sold 5.1K
Granted 126.8K
Granted 104.8K
Granted 104.4K
Granted 169.3K
Granted 185.1K
Granted 96.8K
Granted 78.8K · Bought 20.0K
Granted 128.7K · Sold 447.2K
Granted 118.4K
Granted 54.6K
Granted 5.0K · Bought 91.1K · Sold 45.1K
Granted 23.1K
Granted 18.6K
Granted 204.7K · Sold 185.0K
Granted 20.8K
Granted 9.3K
Granted 5.0K
Granted 6.5K
Granted 158.7K · Sold 152.4K
Granted 198.4K · Bought 150 · Sold 242.8K
Granted 83.1K · Sold 80.2K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Casdin Eli +8 co-filersDirector, 10% owner, Director, 10% owner · 17 transactions | — | 136.13Mas of Mar 2025 | 58.2K | 10.92M | — |
| Casdin Eli +8 co-filersDirector, Director, 10% owner · 14 transactions | — | 130.66Mas of Jun 2024 | 46.47M | 2.30M | — |
| Casdin Eli +7 co-filersDirector, Director, 10% owner · 24 transactions | — | 105.62M | — | 12.71M | — |
| Casdin EliDirector, 10% owner · 17 transactions | — | 91.84M | 21.93M | 1.20M | — |
| Caligan Partners LP +1 co-filer10% owner · 20 transactions | — | 19.24Mas of Jul 2023 | — | 3.06M | — |
| Casdin Private Growth Equity Fund GP, LLC +7 co-filersDirector, Director, 10% owner · 2 transactions | — | 15.19Mas of Jan 2024 | 13.99M | — | — |
| Levin John A +8 co-filersReporting owner · 57 transactions | — | 13.17Mas of Jun 2018 | — | 881.7K | — |
| Levin John A +7 co-filersReporting owner · 14 transactions | — | 12.95Mas of Aug 2018 | — | 59.0K | — |
| Levin John A +7 co-filersReporting owner · 17 transactions | — | 12.82Mas of Oct 2018 | — | 73.4K | — |
| Levin John A +8 co-filersReporting owner · 75 transactions | — | 12.17Mas of Mar 2018 | — | 5.31M | — |
| Levin John A +6 co-filersReporting owner · 3 transactions | — | 11.42Mas of Dec 2018 | — | 35.0K | — |
| Levin John A +8 co-filersReporting owner · 9 transactions | — | 11.39Mas of Dec 2018 | — | 48.8K | — |
| Caligan Partners LP10% owner · 1 transaction | — | 8.58Mas of Dec 2022 | — | — | — |
| Crate Darrell W +8 co-filersReporting owner · 36 transactions | — | 6.91Mas of Sep 2019 | — | — | 2.07M |
| Egholm MichaelPresident & CEO, Director · 26 transactions | — | 6.14M | 7.24M | — | 15.3K |
| Kim Hanjoon AlexChief Financial Officer · 21 transactions | — | 2.53M | 2.85M | — | 4.2K |
| Levin John A +4 co-filersReporting owner · 11 transactions | — | 2.18Mas of Apr 2019 | — | 1.00M | — |
| Versant Affiliates Fund I-A LP +3 co-filers10% owner · 25 transactions | — | 2.09Mas of Feb 2011 | — | — | — |
| Loh JeremyDirector · 3 transactions | — | 1.80Mas of Feb 2011 | — | — | — |
| Mackay SeanSVP & Chief Business Officer · 12 transactions | — | 1.48M | 1.05M | — | 38.6K |
| Casdin Capital, LLC +5 co-filersDirector, 10% owner, Director · 3 transactions | — | 1.20Mas of May 2023 | — | 1.20M | — |
| Biomedical Sciences Investment Fund Pte Ltd. +2 co-filers10% owner · 3 transactions | — | 1.05Mas of Feb 2011 | — | — | — |
| EuclidSR Biotechnology Partners, L.P. +1 co-filer10% owner · 6 transactions | — | 868.9Kas of Feb 2011 | — | — | — |
| Whitaker Raymond JDirector · 6 transactions | — | 868.9Kas of Feb 2011 | — | — | — |
| Cox TroyDirector · 7 transactions | — | 475.7K | 460.5K | — | — |
| Black Jeffrey G.SVP & Chief Financial Officer · 8 transactions | — | 421.6Kas of Aug 2024 | 365.8K | 86.0K | — |
| Jog VikramChief Financial Officer · 264 transactions | — | 350.5Kas of Feb 2023 | 554.0K | 50.0K | 211.9K |
| Carey Thomas D.Director · 6 transactions | — | 344.5K | 423.9K | — | — |
| Eloi Fenel MDirector · 5 transactions | — | 335.3K | 335.3K | — | — |
| Linthwaite Stephen ChristopherPresident & CEO · 71 transactions | — | 326.3Kas of Feb 2022 | 557.2K | 104.0K | 84.8K |
| Witney FrankDirector · 6 transactions | — | 314.2K | 310.0K | — | — |
| Colella Samuel DDirector · 60 transactions | — | 239.3Kas of Mar 2020 | 159.9K | 110.4K | 76.5K |
| Hibbs Kathy LDirector · 4 transactions | — | 236.8K | 316.2K | — | — |
| Barthelemy NicolasDirector · 19 transactions | — | 204.1Kas of Apr 2022 | 109.8K | 92.3K | 5.1K |
| Paya Carlos VDirector · 16 transactions | — | 126.8Kas of Jun 2023 | 126.8K | — | — |
| Clague LauraDirector · 7 transactions | — | 104.8Kas of Jun 2023 | 104.8K | — | — |
| Madaus Martin DDirector · 5 transactions | — | 104.1Kas of Oct 2023 | 104.4K | — | — |
| Khadder NicholasSVP, Gen. Counsel & Secretary · 59 transactions | — | 100.5Kas of May 2022 | 169.3K | — | — |
| Kreger Bradley AllenSVP, Global Operations · 45 transactions | — | 99.1Kas of May 2022 | 185.1K | — | — |
| Burbach Gerhard FDirector · 11 transactions | — | 96.8Kas of Jun 2022 | 96.8K | — | — |
| McPhail StevenChief Commercial Officer · 53 transactions | — | 87.1Kas of Apr 2019 | 78.8K | 20.0K | — |
| Worthington Gajus VincentCHIEF EXECUTIVE OFFICER, Director · 113 transactions | — | 79.2Kas of Aug 2016 | 128.7K | — | 447.2K |
| McCracken ColinChief Commercial Officer · 30 transactions | — | 65.1Kas of Feb 2022 | 118.4K | — | — |
| Colston BillDirector · 3 transactions | — | 59.3Kas of Jun 2022 | 54.6K | — | — |
| Jones Evan/ FaDirector · 19 transactions | — | 58.6Kas of Jul 2017 | 5.0K | 91.1K | 45.1K |
| Jones Patrick SDirector · 5 transactions | — | 23.1Kas of Jun 2019 | 23.1K | — | — |
| Stankovic Ana K.Director · 2 transactions | — | 18.6Kas of May 2021 | 18.6K | — | — |
| Yow Mai ChanSee Remarks · 86 transactions | — | 18.1Kas of Feb 2018 | 204.7K | — | 185.0K |
| Davis Jeremy StevenSVP Chief Commercial Officer · 2 transactions | — | 14.7Kas of Feb 2023 | 20.8K | — | — |
| Lee Jennifer LingSee Remarks · 12 transactions | — | 6.7Kas of Feb 2018 | 9.3K | — | — |
| Young John ADirector · 2 transactions | — | 5.8Kas of Jul 2017 | 5.0K | — | — |
| Unger MarcEVP, R&D and Marketing · 25 transactions | — | 5.7Kas of Aug 2016 | 6.5K | — | — |
| Jones Robert CSee Remarks · 112 transactions | — | 4.3Kas of Aug 2016 | 158.7K | — | 152.4K |
| Smith William MaxwellSee Remarks · 170 transactions | — | 3.7Kas of May 2016 | 198.4K | 150 | 242.8K |
| Walder Fredric TCHIEF OPERATING OFFICER · 28 transactions | — | 2.6Kas of Aug 2015 | 83.1K | — | 80.2K |
| Nussbacher Kenneth JDirector · 1 transaction | — | 169as of Aug 2011 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: +35.70M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.